transitioning from semaglutide to tirzepatide Switching Tirzepatide: A Provider's Guide Switching from tirzepatide to semaglutide

Study design: Randomized, double-blind, parallel-group, single-center trial evaluating the within-subject, day-to-day variability and glucose-lowering effect of Tresiba U-100 (n=27) vs insulin glargine U-100 (n=27) under steady-state conditions

doi: 10.1158/1078-0432.CCR-12-1045 14 AliRAouidaMAlhaj SulaimanAMadhuSudanSRamotarD

elara exists to raise the standard of care in womens healthcare

If you are still treating protein as a single ingredient rather than a spectrum of different consumer needs, you are missing the actual opportunity

Heres a quick guide to some of the most notable published and ongoing trials in the STEP series: STEP-1 is the first and largest STEP trial, involving 1961 nondiabetic but obese or overweight individuals

If you have ever been diagnosed with MTC, or if a first-degree relative (parent, sibling, child) has been diagnosed with MTC, tirzepatide should not be used